Research & development
-
SAHPRA institutes rolling review process for COVID-19 vaccines in SA
SAHPRA has launched a rolling review process to fast-track COVID-19 vaccine approvals, ensuring every vaccine meets strict safety, quality, and efficacy standards. Discover how this approach keeps South Africans protected while accelerating access to vital treatments.
-
Seven-day countdown to ending maskne with Miracne
Battling stubborn maskne? Discover how Miracne targets mask-related breakouts in just seven days, backed by real skin science and clear results. Take the first step to smoother, healthier skin—find out how!
-
Betadine presents a new non-antibiotic solution for treatment of Bacterial Vaginosis
Discover how BETADINE BV Gel, a non-antibiotic treatment from Mundipharma South Africa, addresses stubborn and recurrent Bacterial Vaginosis—offering new hope where standard antibiotics often fall short. Find out why this innovation could change BV care for South African women.
-
Environ founder Dr Des Fernandes receives Lifetime Achievement Award
Dr Des Fernandes, founder of Environ Skin Care, has received the Skin Cancer Foundation of South Africa’s first Lifetime Achievement Award for pioneering work in skin rejuvenation and photoprotection. Discover how his 30 years of innovation have reshaped skincare both locally and worldwide.
-
Eco-friendly barrier identified to improve paper packaging recyclability
A breakthrough from Aquapak Polymers could make paper packaging truly recyclable—thanks to a new, fully soluble barrier that replaces plastic without sacrificing performance. Discover how this innovation helps reduce landfill waste while meeting the strict demands of food and household packaging.
-
Explore Symrise’s creative technologies for product protection
Discover how Symrise’s innovative SymOcide technologies protect your cosmetic products and keep consumers safe. Explore advanced antimicrobial solutions designed to meet evolving market expectations and regulatory demands—ensuring freshness and trusted quality in every formulation.
-
Merck accelerates development of synthetic cholesterol to meet COVID-19 vaccine demand
Merck has fast-tracked a high-purity synthetic cholesterol, boosting lipid production by 50 times to help meet soaring COVID-19 vaccine demand. Discover how this breakthrough brings life-saving therapies to patients faster and sets a new standard in quality and scalability for biomanufacturers worldwide.
-
Clinical trials impacted by COVID-19
With COVID-19 cases and new variants on the rise, clinical trials face ongoing disruption. While more trials are restarting, progress is slow, and many patients remain hesitant to enroll. Discover how the industry is adapting to these challenges and what it means for the future of medical research.
-
First-ever treatment for white patches on skin launched by Bella Aurora
Discover Repigment, the innovative new treatment from Bella Aurora that offers hope for those living with white skin patches. Backed by leading dermatologists, this breakthrough promises real results and renewed confidence—find out how it’s changing lives.
-
Cobiosa’s Sugicare: The future of neuro-wellness skin care
Discover how Cobiosa’s Sugicare uses neuro-cosmetics to support both your skin and mood, responding to the growing demand for natural wellness solutions after a stressful year. Explore the future of skincare driven by science, real emotions, and the power to help you feel better inside and out.
-
New podcast tackles trends in beauty and personal care that are shaping the industry
Discover the science—and the hype—behind today’s hottest beauty and personal care trends in a new podcast series hosted by industry experts. Tune in for insider insights, starting with a deep dive into ingestible beauty products and the evidence shaping this fast-growing market.
-
SAHPRA finds no causal relationship between Johnson and Johnson vaccine and blood clot development
SAHPRA’s review of the Sisonke study finds no link between the Johnson & Johnson COVID-19 vaccine and blood clots. Discover the latest safety findings and what they mean for South Africa’s vaccination drive.
